|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis6 j& F$ Y0 w& x5 s: f
was to close its brain research facility in Basel, Switzerland,% r4 l" y+ h. P1 R
the story noted that this move closely followed similar cuts2 }/ J, Z0 T$ Y* j
by rival pharmaceutical firms. As a report from the European College' o7 V6 \. Z! Z6 C' @
of Neuropsychopharmacology8 U( a( a0 O* Y: S4 z- c
had warned a few months earlier, the
4 M- W: p" K- x& u0 G* h6 e$ c9 Habandonment of research into new psychiatric drugs by AstraZeneca,
' P y1 J1 d, FGlaxoSmithKline
8 j' H* t Y/ B; s1 D( G6 M+ Hand others meant that “withdrawal of research
9 i8 R% }: b0 T6 Rresources is a withdrawal of hope for patients and their families”.
. F+ Q" Y$ ^8 Q* M$ ]1 k% N
7 B* g, D) X4 ?0 Y) `) n9 G6 M- j1 N, t* l6 Y5 R" \
回复有免费下载链接
4 }. Q4 r, f5 \0 R
`. C h* V9 N4 Q |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
